Evidence map›Paper›PMID 25284779›Full record

ArticleCell reports2014

Dnase2a deficiency uncovers lysosomal clearance of damaged nuclear DNA via autophagy.

Yuk Yuen Lan, Diana Londoño, Richard Bouley, Michael S Rooney, Nir Hacohen

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 149 papers.

0numbers the graph read from it
0cells of the map it votes in
149citing papers in PubMed
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

149 citing papers in PubMed, 228 citations in OpenAlex.

  1. Autophagy modulation in cancer.Nature reviews. Drug discovery · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Regulation of Innate Immune Signaling by Autophagy.International journal of molecular sciences · 2026
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. The Immunogenic Role of Self-DNA in T Cell Immunity.Clinical reviews in allergy & immunology · 2025
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Deciphering the Role of Oroxylin A in Liver Fibrosis.Drug design, development and therapy · 2025
    Review
  19. Review
  20. Article

89 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Yuk Yuen LanCenter for Immunology and Inflammatory Diseases, Massachusetts General Hospital, 149 13(th) Street, Charlestown, MA 02129, USA; Broad Institute, 415 Main Street, Cambridge, MA 02142, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.
Diana LondoñoCenter for Immunology and Inflammatory Diseases, Massachusetts General Hospital, 149 13(th) Street, Charlestown, MA 02129, USA.
Richard BouleyCenter for Systems Biology, Program in Membrane Biology and Nephrology Division, Massachusetts General Hospital, 185 Cambridge Street, Boston, MA 02114, USA.
Michael S RooneyBroad Institute, 415 Main Street, Cambridge, MA 02142, USA; Harvard/MIT Division of Health Sciences and Technology, Cambridge, MA 02139, USA.
Nir HacohenCenter for Immunology and Inflammatory Diseases, Massachusetts General Hospital, 149 13(th) Street, Charlestown, MA 02129, USA; Broad Institute, 415 Main Street, Cambridge, MA 02142, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA. Electronic address: nhacohen@partners.org.
Massachusetts General Hospital · USBroad Institute · USHarvard–MIT Division of Health Sciences and Technology · USHarvard University · US

Funding

Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Ramnik J Xavier · 1991 to 2026
$35.3M
Transgenic CoreP30DK057521 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI FLOREZ, JOSE CARLOS · 2000 to 2019
$31.4M
TRAINING IN CELL STRUCTURE AND FUNCTION IN NEPHROLOGYT32DK007540 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI BROWN, DENNIS, SOBERMAN, ROY · 1986 to 2021
$7.2M
Revealing pathogen-sensing pathways using RNAi librariesDP2OD002230 · OD · MASSACHUSETTS GENERAL HOSPITAL · PI HACOHEN, NIR · 2007 to 2007
$2.6M
Research Training in Allergy and Immunology at Massachusetts General HospitalT32AI060548 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI LUSTER, ANDREW D · 2006 to 2010
$799k
NIAID NIH HHS T32 AI060548NIAID NIH HHS T32 AI060548-04NIAID NIH HHS T32 AI060548-05NIDDK NIH HHS DK43351NIDDK NIH HHS DK57521NIDDK NIH HHS P30 DK043351NIDDK NIH HHS P30 DK057521NIDDK NIH HHS T32 DK007540NIDDK NIH HHS T32 DK007540-22NIH HHS DP2 OD002230
6 · The paper itself

Abstract

Deficiencies in DNA-degrading nucleases lead to accumulation of self DNA and induction of autoimmunity in mice and in monogenic and polygenic human diseases. However, the sources of DNA and the mechanisms that trigger immunity remain unclear. We analyzed mice deficient for the lysosomal nuclease Dnase2a and observed elevated levels of undegraded DNA in both phagocytic and nonphagocytic cells. In nonphagocytic cells, the excess DNA originated from damaged DNA in the nucleus based on colocalization studies, live-cell imaging, and exacerbation by DNA-damaging agents. Removal of damaged DNA by Dnase2a required nuclear export and autophagy-mediated delivery of the DNA to lysosomes. Finally, DNA was found to accumulate in Dnase2a(-/-) or autophagy-deficient cells and induce inflammation via the Sting cytosolic DNA-sensing pathway. Our results reveal a cell-autonomous process for removal of damaged nuclear DNA with implications for conditions with elevated DNA damage, such as inflammation, cancer, and chemotherapy.

Indexed as

DNA DamageAnimalsAutophagyCell NucleusDNAEndodeoxyribonucleasesHumansLysosomesMicePhagocytesdeoxyribonuclease IIDNAEndodeoxyribonucleases

Identifiers

PMID25284779
PMCPMC4555847
OpenAlexW1993956311

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.